Abstract:
Mulberry (Morus alba L., Moraceae) is one of the most valuable and rich in phytochemicals plant. Morusin is a prenylated flavonoid present in mulberry roots and leaves. The in vitro antibacterial activity of morusin and its interactions with conventional antibiotics (oxacillin, amoxicillin and gentamicin) were evaluated against four methicillin resistant Staphylococcus aureus clinical isolates (MRSA T1 – T4) with resistance to oxacillin and cefoxitin which had been isolated from dogs with various pathologies. Minimum inhibitory concentrations (MICs) were determined by the microdilution method. The interactions were assessed by the chequerboard method - with interpretation through fractional inhibitory concentration index (FICI) and isobologram analysis. The interactions were confirmed by the time-kill assay. MICs varied between 3.125 and 6.25μg/mL for morusin alone against all four MRSA clinical isolates. Chequerboard method showed synergies for the combinations: morusin – oxacillin (FICI=0.024 - 0.27), morusin – amoxicillin (FICI=0.024 - 0.27) and morusin - gentamicin (FICI=0.05 - 0.12) against all four tested isolates. Time-kill assay determined synergies for the following combinations: morusin – oxacillin against MRSA T1, morusin – amoxicillin against MRSA T2 and morusin - gentamicin against all four isolates. Our preliminary study evaluated the antibacterial activity of morusin and its ability to act synergistically with antibiotics; these results suggest that morusin might be a promising strategy to overcome antibiotic resistence.
